Wednesday 7 November 2018 6.30pm to 8.30pm
Royal Academy of Engineering, London SW1Y 5DG
Billy Boyle, Co-founder and CEO, David Ruiz-Alonso, Co-founder and COO and Max Allsworth, Chief Science Officer from Owlstone Medical, will share their story of the succesful development of the ReCIVA Breath Sampler, the first device capable of capturing breath samples for analysis in a robust and reproducible way. The system can identify chemical 'biomarkers' in human breath for a variety of diseases, including cancer.
Sabah Meddings, Business Reporter at the Sunday Times, will host the event. Find out more and register here.
Owlstone Medical has created a device that is dependable and non-intrusive, and has the potential to revolutionise the way we diagnose and treat a vast array of diseases. The societal benefit is clear to see, and I believe they could realise their vision of saving more than a billion dollars in global healthcare costs and saving hundreds of thousands of lives. - Dr Dame Sue Ion DBE FREng FRS , Chair of the MacRobert Award judging panel
Supported by The MacRobert Trust and The Worshipful Company of Engineers.